AtriCure ATRC

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
-$1.73 (-4.77%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0

Relative Strength Index (RSI)

- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

- The RSI is calculated using the following formula:

RSI = 100 - (100 / (1 + RS))

Where RS is the ratio of the average gains to the average losses over a specified period.

- The default time period used is 14 days.

- RSI values range between 0 and 100.

RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

About

Business overview of AtriCure (ATRC)
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.

Key Insights

Critical company metrics and information

  • Latest Closing Price

    $34.52

  • Market Cap

    $1.68 Billion

  • Price-Earnings Ratio

    -41.59

  • Total Outstanding Shares

    48.70 Million Shares

  • Total Employees

    1,200

  • Dividend

    No dividend

  • IPO Date

    August 5, 2005

  • SIC Description

    Surgical & Medical Instruments & Apparatus

  • Primary Exchange

    NASDAQ

  • Type

    Common Stock

  • Headquarters

    7555 innovation way, Mason, OH, 45040

  • Homepage

    https://www.atricure.com

Historical Stock Splits

Execution DateSplit Amount
No Historical Stock Splits

Cash Flow Statement

October 1, 2023 to September 30, 2024
MetricValue
Net Cash Flow From Operating Activities, Continuing$10.40 Million
Net Cash Flow From Financing Activities, Continuing$-2.98 Million
Net Cash Flow From Investing Activities$42.14 Million
Net Cash Flow$49.74 Million
Net Cash Flow From Investing Activities, Continuing$42.14 Million
Exchange Gains/Losses$180,000

Income Statement

October 1, 2023 to September 30, 2024
MetricValue
Income Tax Expense/Benefit$1.13 Million
Basic Average Shares$140.78 Million
Costs And Expenses$485.36 Million
Selling, General, and Administrative Expenses$286.86 Million
Research and Development$82.02 Million
Gross Profit$334.72 Million

Comprehensive Income

October 1, 2023 to September 30, 2024
MetricValue
Comprehensive Income/Loss$-36.88 Million
Other Comprehensive Income/Loss$-36.88 Million
Comprehensive Income/Loss Attributable To Noncontrolling Interest$0
Comprehensive Income/Loss Attributable To Parent$-36.88 Million
Other Comprehensive Income/Loss Attributable To Parent$2.04 Million

Balance Sheet

October 1, 2023 to September 30, 2024
MetricValue
Assets$615.07 Million
Long-term Debt$61.87 Million
Liabilities And Equity$615.07 Million
Other Current Assets$192.74 Million
Wages$34.51 Million
Intangible Assets$58.35 Million

Historical Dividends

Announcement DatePayment DateRecord DateAmountFrequency
No historical dividends

Recent Headlines From The Web

Latest news, press releases, and media coverage about ATRC from trusted financial sources
    All TickersEarnings CalendarNews ArticlesAbout UsPrivacy & Cookies Info

    ⓒ 2025 Financhle. All Rights Reserved.